AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Teladoc Health, Inc.
Video analysis: TDOC
All videosNo video analysis for this stock yet. Request one from our team.
News: TDOC
Teladoc: Integrated Care And Free Cash Flow Could Bring It Back To Life
Teladoc Health trades near multi-year lows, with the market pricing in deep distress despite meaningful free cash flow and manageable debt. BetterHelp's rapid decline drags on TDOC, but Integrated Care's improving margins and growing revenue per member offer stabilization. TDOC's valuation is extremely depressed, trading at just 7–8x expected free cash flow, with fair value estimates suggesting significant upside even under conservative scenarios.
Why Teladoc (TDOC) Outpaced the Stock Market Today
Teladoc (TDOC) reached $6.16 at the closing of the latest trading day, reflecting a +1.15% change compared to its last close.
Dow, Nasdaq Down Triple Digits as Brent Crude Tops July Peak
Major Indexes are moving lower once again as investors focus on geopolitical tensions
2 Beaten-Down Stocks to Avoid Right Now
Don't catch a falling knife.
Here's Why Teladoc's Integrated Care Business Deserves More Attention
TDOC's Integrated Care is driving profitability as chronic care gains traction, potentially making it the company's key earnings driver.
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to a new employee.
Here's Why Investors Should Stay Neutral on TDOC Stock for Now
Teladoc Health's growth is supported by chronic care, international expansion and Teladoc One, but BetterHelp weakness and losses temper the outlook.
Connor Clark & Lunn Investment Management Ltd. Buys Shares of 87,511 Teladoc Health, Inc. $TDOC
Connor Clark and Lunn Investment Management Ltd. bought a new position in Teladoc Health, Inc. (NYSE: TDOC) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 87,511 shares of the health services provider's stock, valued at approximately $742,000. Several other hedge funds
